UNLIMITED TURBO SHORT - ZOETIS Stock

Certificat

DE000PC3TND9

Real-time Boerse Frankfurt Warrants 11:05:30 2024-07-17 am EDT
1.63 EUR -5.78% Intraday chart for UNLIMITED TURBO SHORT - ZOETIS
Current month-33.46%
1 month-39.51%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-17 1.63 -5.78%
24-07-16 1.73 -18.40%
24-07-15 2.12 +3.41%
24-07-12 2.05 -3.76%
24-07-11 2.13 -16.80%

Real-time Boerse Frankfurt Warrants

Last update July 17, 2024 at 11:05 am EDT

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying ZOETIS INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC3TND
ISINDE000PC3TND9
Date issued 2024-01-23
Strike 200.9 $
Maturity Unlimited
Parity 10 : 1
Emission price 1.16
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 5.23
Lowest since issue 0.07
Spread 0.02
Spread %1.20%

Company Profile

Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows: - pets (64.4%): cats and dogs (94.9% of net sales) and horses (5.1%); - livestock (34.5%): cattle (51.6% of sales), swine (20.2%), poultry (17.1%), fish (7.6%) and other (3.5%); - other (1.1%). Net sales break down by family of products into parasiticides (23%), vaccines (21.3%), dermatological products (16.4%), anti-infectives (13.4%), medical food additives (4.5%), diagnostic products (4.4%) and other (17%). At the end of 2022, the group has 29 production sites worldwide. The United States accounts for 53.4% of net sales.
Sector
-
More about the company

Ratings for Zoetis Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Zoetis Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
182.9 USD
Average target price
210.2 USD
Spread / Average Target
+14.89%
Consensus